Abstract
UDP-glucuronosyltransferase (UDP) catalyzes a broad spectrum of endobiotic and xenobiotics. It is the isoform of the UGT1 family, which are made from the complex gene locus by an alternative combination of one of the unique first exons with the commonly used exons. UDP is believed to be involved in cellular activity and signaling process associated with detoxification. In this study, rats were orally administered with 18β-glycyrrhetinic acid (GA) for four weeks before rats were sacrificed. The mRNA was extracted from the liver and cDNA was prepared by reverse transcription method. By PCR and Northern blot analysis, UGT1A8 mRNA level was found to be increased in the treatment group (P < 0.05). The results showed that the mRNA expression of UGT1A8 could be induced both by GA and the licorice extract. GA was identified to be the active component of the aqueous extract of licorice responsible for induction of UGT1A8 in the rat liver. The results suggest a transcriptional control of the UGT1A8 synthesis can be modulated by phytochemicals in the rat liver. The increased UDP activity could enhance detoxification of toxicants.
Keywords: UGT1A8, induction, transcription, expression, 18β-glycyrrhetinic acid.
Protein & Peptide Letters
Title:18β-glycyrrhetinic Acid Induces UDP-glucuronosyltransferase in Rats
Volume: 20 Issue: 12
Author(s): Kai Woo Lee and Wing Shing Ho
Affiliation:
Keywords: UGT1A8, induction, transcription, expression, 18β-glycyrrhetinic acid.
Abstract: UDP-glucuronosyltransferase (UDP) catalyzes a broad spectrum of endobiotic and xenobiotics. It is the isoform of the UGT1 family, which are made from the complex gene locus by an alternative combination of one of the unique first exons with the commonly used exons. UDP is believed to be involved in cellular activity and signaling process associated with detoxification. In this study, rats were orally administered with 18β-glycyrrhetinic acid (GA) for four weeks before rats were sacrificed. The mRNA was extracted from the liver and cDNA was prepared by reverse transcription method. By PCR and Northern blot analysis, UGT1A8 mRNA level was found to be increased in the treatment group (P < 0.05). The results showed that the mRNA expression of UGT1A8 could be induced both by GA and the licorice extract. GA was identified to be the active component of the aqueous extract of licorice responsible for induction of UGT1A8 in the rat liver. The results suggest a transcriptional control of the UGT1A8 synthesis can be modulated by phytochemicals in the rat liver. The increased UDP activity could enhance detoxification of toxicants.
Export Options
About this article
Cite this article as:
Lee Woo Kai and Ho Shing Wing, 18β-glycyrrhetinic Acid Induces UDP-glucuronosyltransferase in Rats, Protein & Peptide Letters 2013; 20 (12) . https://dx.doi.org/10.2174/092986652012131112124033
DOI https://dx.doi.org/10.2174/092986652012131112124033 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Carbon Monoxide in Renal Physiology, Pathogenesis and Treatment of Renal Disease
Current Pharmaceutical Design VEGF Inhibitors in Cancer Therapy
Current Pharmaceutical Design Macrocyclic Inhibitors of Hsp90
Current Topics in Medicinal Chemistry Release of α-Glutathione s-Transferase (α-GST) and Hepatocellular Damage Induced by Helicobacter pylori and Eradication Treatment
Current Drug Safety Conjugation of Phthalocyanine Photosensitizer with Poly(amidoamine) Dendrimer: Improved Solubility, Disaggregation and Photoactivity Against HepG2 Cells
Current Cancer Drug Targets Molecular Diagnosis in Autoimmune Skin Blistering Conditions
Current Molecular Medicine Fetuin-A: A Multifunctional Protein
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Current Molecular Medicine A Computational Approach to Identify Novel Potential Precursor miRNAs and their Targets from Hepatocellular Carcinoma Cells
Current Bioinformatics Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets The Cross-talk between Tristetraprolin and Cytokines in Cancer
Anti-Cancer Agents in Medicinal Chemistry Carbohydrates: Potential Sweet Tools Against Cancer
Current Medicinal Chemistry Role of the Retinoblastoma Tumor Suppressor in the Maintenance of Genome Integrity
Current Molecular Medicine Synthetic and Natural Products as Iron Chelators
Current Topics in Medicinal Chemistry Ruthenium Complexes as Anticancer Agents
Current Medicinal Chemistry Epigenetic Basis of Individual Variability to Major Psychosis
Current Pharmacogenomics and Personalized Medicine Can Combined Therapy Benefit Immune Checkpoint Blockade Response in Hepatocellular Carcinoma?
Anti-Cancer Agents in Medicinal Chemistry Allelic Variations in CYP2D6 Gene and Susceptibility to Cervical Cancer
Drug Metabolism Letters Emerging Immunotargets in Bladder Cancer
Current Drug Targets Deep Penetration of Nanoparticulate Drug Delivery Systems into Tumors: Challenges and Solutions
Current Medicinal Chemistry